Review of treatment options for vaccine-associated feline sarcoma

Journal of the American Veterinary Medical Association

Volumn 213, Issue 10, 1998, Pages 1426-1427

  Couto, C Guillermo ^a   Macy, Dennis W ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; METHODOLOGY; REVIEW; SARCOMA; SOFT TISSUE TUMOR; VACCINATION;

ANIMALS; CAT DISEASES; CATS; SARCOMA; SOFT TISSUE NEOPLASMS; VACCINATION; VACCINES;

EID: 0032534093     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 1994;205:1425-1429.
2. Kass PH, Barnes WG Jr, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993;203:396-405.
3. Lester S, Clemett T, Burt A. Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993): J Am Anim Hosp Assoc 1996;32:91-95.
4. Scott FW, Geissinger C. Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine. Feline Pract 1997;25:12-19.